zika
viru
zikv
arthropodborn
viru
transmit
aed
mosquito
belong
flaviviru
genu
also
includ
pathogen
west
nile
viru
wnv
yellow
fever
viru
yfv
japanes
enceph
viru
jev
dengu
viru
denv
zika
viru
first
isol
sentinel
monkey
zika
forest
uganda
sinc
zikv
isol
human
mosquito
throughout
africa
southeast
asian
countri
phylogenet
analysi
nonstructur
protein
encod
region
disclos
three
zikv
lineag
east
african
west
african
asian
sequenc
uganda
seneg
belong
east
african
cluster
sequenc
nigeria
also
sequenc
seneg
cluster
west
african
lineag
viral
sequenc
recov
recent
outbreak
belong
asian
lineag
strain
isol
american
south
asian
pacif
countri
utero
exposur
asian
lineag
zikv
might
lead
microcephali
development
malform
includ
calcif
arthrogryposi
ventriculomegali
lissencephali
cerebellar
atrophi
ocular
abnorm
although
zikv
lineag
infect
human
sever
manifest
report
utero
infect
associ
asian
lineag
includ
brazilian
isol
asian
zikv
strain
detect
brain
amniot
fluid
newborn
stillborn
microcephali
african
strain
shown
kill
human
neuroprogenitor
cell
vitro
well
decreas
growth
rate
brain
organoid
symptom
infect
asian
zikv
includ
lowgrad
fever
headach
rash
conjunct
arthriti
myalgia
mild
symptom
headach
lowgrad
fever
report
human
volunt
infect
african
zikv
strain
howev
rare
instanc
infect
asian
zikv
associ
case
syndrom
meningoenceph
current
vaccin
specif
therapeut
approach
prevent
treat
zikv
infect
alarm
increas
number
countri
affect
potenti
viral
spread
global
travel
sexual
transmiss
urgent
need
find
treatment
capabl
lessen
effect
diseas
inhibit
transmiss
chloroquin
weak
base
rapidli
import
acid
vesicl
increas
ph
approv
food
drug
administr
fda
treat
malaria
long
prophylact
prescrib
pregnant
women
risk
exposur
plasmodium
parasit
chloroquin
inhibit
phdepend
step
viral
replic
restrict
human
immunodefici
viru
hiv
influenza
viru
denv
jev
wnv
infect
investig
antivir
effect
chloroquin
asian
use
brazilian
isol
african
zikv
infect
differ
cell
type
vero
cell
atcc
manassa
va
usa
deriv
kidney
african
green
monkey
grown
dmem
high
glucos
gibco
thermo
fisher
scientif
waltham
usa
supplement
fetal
bovin
serum
fb
gibco
human
brain
microvascular
endotheli
cell
hbmec
kind
gift
dr
julio
scharfstein
feder
univers
rio
de
janeiro
rio
de
janeiro
brazil
hbmec
isol
perform
previous
describ
cell
cultur
dmem
high
glucos
supplement
fb
cell
line
deriv
aed
albopictu
cell
atcc
manassa
va
usa
grown
leibovitz
medium
gibco
supplement
gl
tryptos
phosphat
broth
sigma
aldrich
boston
usa
mm
glutamin
gibco
sodium
bicarbon
gibco
nonessenti
amino
acid
gibco
fb
neural
stem
cell
nsc
deriv
human
induc
pluripot
stem
cell
ipsc
ipsc
provid
biobank
ipsc
brazilian
ministri
health
conep
accord
supplier
fibroblast
reprogram
use
protocol
develop
paulsen
et
al
transduc
cytotuneip
sendai
kit
thermo
fisher
scientif
waltham
usa
ipsc
present
normal
karyotyp
express
pluripot
marker
cell
cultur
cultur
media
gibco
matrigel
bd
bioscienc
san
jose
ca
usa
coat
surfac
ipsc
coloni
manual
passag
everi
day
reach
confluenc
maintain
humidifi
air
produc
nsc
human
ipsc
expos
serumfre
neural
induct
medium
gibco
contain
neurobas
medium
gibco
pluripot
stem
cell
neural
induct
supplement
gibco
accord
manufactur
protocol
briefli
medium
chang
everi
day
day
initi
nsc
split
grown
neural
expans
medium
advanc
neurobas
medium
neural
induct
supplement
gibco
nsc
use
four
passag
neural
expans
media
mous
central
nervou
system
cn
cell
harvest
swiss
mous
embryo
embryo
day
grown
h
free
float
neurospher
neurobas
cultur
media
gibco
supplement
gibco
chloroquin
diphosph
kindli
suppli
farmanguinho
fiocruz
rio
de
janeiro
brazil
lyophil
powder
dilut
doubl
distil
water
mm
chloroquin
solut
filter
membran
store
zikv
strain
mr
ugandaafrica
access
kindli
provid
dr
davi
ferreira
feder
univers
rio
de
janeiro
rio
de
janeiro
brazil
isol
rhesu
monkey
inject
intracerebr
swiss
mice
sever
passag
zikv
br
recifebrazil
zikv
access
kindli
provid
dr
marli
cordeiro
centro
de
pesquisa
aggeu
recif
brazil
isol
patient
present
classic
symptom
zikv
infect
virus
propag
vero
cell
respect
briefli
cell
infect
zikv
multipl
infect
moi
incub
h
inoculum
remov
replac
dmem
highglucos
vero
leibovitz
growth
media
supplement
fb
day
condit
medium
harvest
centrifug
g
sterilefilt
remov
cell
cellular
debri
viru
stock
store
viru
titer
determin
plaqu
assay
perform
vero
cell
viru
stock
sampl
serial
dilut
adsorb
confluent
monolay
h
inoculum
remov
cell
overlaid
semisolid
medium
constitut
alphamem
gibco
contain
carboxymethyl
cellulos
sigma
aldrich
fb
gibco
cell
incub
day
cell
fix
formaldehyd
cell
stain
crystal
violet
ethanol
plaqu
visual
titer
express
plaqu
form
unit
pfu
per
millilit
vero
cell
hbmec
nsc
infect
zikv
mr
zikv
br
strain
moi
h
inoculum
remov
medium
contain
chloroquin
ad
cell
day
cell
fix
paraformaldehyd
sigma
aldrich
phosphat
buffer
salin
pb
min
room
temperatur
wash
pb
cell
permeabil
triton
sigma
aldrich
pb
wash
pb
block
pb
fb
cell
incub
panflaviviru
antibodi
rais
zikv
envelop
e
protein
produc
hybridoma
atcc
dilut
pb
fb
cell
label
donkey
antimous
alexa
fluor
antibodi
thermo
scientif
waltham
usa
dilut
pb
fb
analyz
flow
cytometri
bd
accuri
becton
dickinson
compani
franklin
lake
nj
usa
zikv
infect
vero
hbmec
nsc
seed
black
plate
clear
bottom
infect
zikv
mr
zikv
br
strain
moi
h
neurospher
seed
coverslip
infect
zikv
pfu
infect
viral
inoculum
remov
cell
incub
medium
contain
chloroquin
day
depend
cell
type
cell
neurospher
fix
paraformaldehyd
pb
min
room
temperatur
fix
remov
sampl
wash
three
time
pb
block
unspecif
bind
antibodi
permeabil
perform
pb
supplement
bovin
serum
albumin
bsa
sigma
aldrich
triton
min
room
temperatur
incub
antibodi
perform
follow
manufactur
instruct
abcam
cambridg
cambridgeshir
uk
antibodi
dilut
pb
bsa
incub
cell
h
wash
three
time
pb
cell
incub
secondari
antibodi
coupl
alexa
fluorochrom
thermo
fisher
scientif
min
wash
five
time
coverslip
neurospher
mount
prolong
gold
mount
medium
thermo
fisher
scientif
sampl
imag
use
either
leica
leica
spe
leica
biosystem
wetzlar
hess
de
confoc
microscop
nikon
tokyo
japan
invert
microscop
coupl
leica
camera
leica
biosystem
wetzlar
germani
vero
hbmec
nsc
expos
zikv
mr
moi
h
inoculum
remov
chloroquinecontain
medium
ad
cell
five
day
postinfect
celltit
blue
reagent
promega
madison
wi
usa
ad
well
incub
h
fluoresc
measur
nm
except
cell
celltit
blue
ad
three
day
postinfect
mean
fluoresc
intens
mfi
standard
deviat
display
order
calcul
half
maximum
effect
concentr
protect
cell
death
caus
zikv
infect
mfi
valu
zikv
control
subtract
everi
condit
valu
normal
mock
control
data
plot
hill
paramet
sigmoid
regress
perform
sigma
plot
systat
softwar
inc
san
jose
ca
usa
vero
cell
hbmec
nsc
incub
medium
contain
chloroquin
day
nsc
day
vero
hbmec
celltit
blue
reagent
promega
ad
well
incub
h
fluoresc
measur
nm
order
calcul
cytotox
concentr
mfi
valu
normal
untreat
control
data
plot
hill
paramet
sigmoid
regress
perform
sigma
plot
systat
softwar
inc
vero
cell
inocul
zikv
mr
moi
h
cell
wash
three
time
cold
pb
remov
unbound
viru
treat
chloroquin
ad
differ
time
point
h
postinfect
condit
media
collect
h
postinfect
analyz
product
viru
particl
viral
rna
content
amount
infecti
viru
particl
viral
rna
extract
quantit
revers
transcript
polymeras
chain
reaction
rtqpcr
perform
titer
infecti
viru
particl
determin
plaqu
assay
vero
cell
infect
zikv
zikv
br
strain
moi
h
viru
input
wash
three
time
cold
pb
cell
treat
chloroquin
h
supernat
collect
rna
extract
analyz
rel
quantif
rtqpcr
supernat
also
evalu
plaqu
assay
quantit
infecti
viru
particl
viral
rna
extract
supernat
infect
cell
use
qiamp
minielut
viru
spin
qiagen
hilden
de
follow
manufactur
recommend
zikv
detect
perform
use
one
step
taqman
rtqpcr
thermo
fisher
scientif
realtim
pcr
system
appli
biosystem
primer
probe
describ
elsewher
threshold
cycl
ct
determin
ct
chloroquin
treat
ct
untreat
calcul
fold
reduct
viru
particl
releas
includ
defect
viral
particl
calcul
mean
standard
deviat
sd
calcul
assay
one
way
analysi
varianc
anova
conduct
use
nonparametr
test
follow
dunn
multipl
comparison
test
pvalu
consid
signific
analys
perform
graphpad
prism
graphpad
softwar
san
diego
ca
usa
sampl
size
provid
respect
figur
legend
character
antivir
properti
chloroquin
vero
cell
model
wide
use
studi
viral
infect
vero
cell
infect
zikv
moi
ie
pfucel
treat
day
chloroquin
concentr
rang
viral
infect
assess
use
antibodi
detect
flaviviru
envelop
e
protein
observ
chloroquin
treatment
decreas
number
zikvinfect
cell
dosedepend
manner
flow
cytometri
analysi
show
reduct
zikvinfect
cell
cultur
treat
chloroquin
respect
compar
untreat
infect
cell
figur
immunofluoresc
stain
corrobor
result
figur
addit
chloroquin
decreas
product
infecti
figur
total
figur
viru
particl
includ
defect
viral
particl
zikvinfect
cell
confirm
viral
inhibit
independ
chloroquin
cytotox
viabil
uninfect
cell
treat
chloroquin
day
analyz
chloroquin
impact
cell
viabil
concentr
lower
figur
analyz
whether
chloroquin
treatment
could
protect
vero
cell
zikv
infect
assess
cell
viabil
chloroquin
rang
increas
cell
viabil
figur
microcephali
case
neurolog
disord
associ
infect
strain
zikv
asian
lineag
detect
french
polynesia
america
determin
inhibit
spectrum
chloroquin
zikv
infect
vero
cell
infect
brazilian
isol
asian
lineag
zikv
br
chloroquin
decreas
percentag
cell
infect
brazilian
isol
respect
figur
c
moreov
viral
rna
level
supernat
vero
cell
quantifi
direct
measur
zikv
infect
treatment
chloroquin
led
reduct
level
viral
rna
detect
supernat
figur
inhibit
viral
infect
mediat
chloroquin
occur
earli
later
stage
viral
replic
cycl
evalu
step
viral
cycl
suscept
inhibit
chloroquin
ad
vero
cell
differ
time
point
postinfect
zikv
supernat
collect
h
postinfect
viru
product
evalu
rel
quantif
viral
rna
untreat
control
rtqpcr
viru
titer
also
determin
plaqu
assay
vero
cell
incub
vero
cell
chloroquin
h
postinfect
greater
impact
product
zikv
particl
decreas
viral
rna
control
figur
addit
chloroquin
min
h
postinfect
abl
reduc
viru
releas
fold
untreat
infectedcel
howev
chloroquin
ad
h
postinfect
minor
effect
viral
product
figur
result
confirm
quantif
zikv
infecti
particl
releas
chloroquin
treatment
figur
data
confirm
chloroquin
interfer
earli
stage
zikv
replic
cycl
consid
zikv
infect
hbmec
investig
whether
chloroquin
could
inhibit
viral
infect
cell
chloroquin
reduc
number
zikv
hbmec
respect
figur
concentr
noncytotox
figur
protect
approxim
hbmec
zikv
infect
demonstr
increas
cell
viabil
figur
neural
stem
cell
key
cell
process
corticogenesi
give
rise
three
main
cell
type
central
nervou
system
neuron
astrocyt
oligodendrocyt
deplet
nsc
pool
one
main
mechan
respons
primari
microcephali
evalu
chloroquin
could
protect
cell
zikv
infect
nsc
expos
chloroquin
day
chloroquin
treatment
decreas
number
nsc
infect
zikv
cell
viabil
assess
protect
nsc
zikv
infect
without
cytotox
effect
figur
similar
result
observ
nsc
infect
brazilian
strain
figur
neuroprogenitorenrich
neurospher
subject
differenti
cultur
condit
gener
neuron
group
recent
demonstr
zikv
infect
affect
neurospher
size
neurit
extens
neuron
differenti
previous
observ
neurospher
infect
zikv
strain
show
convolut
misshapen
neurit
neurit
extens
evalu
chloroquin
treat
cultur
microtubuleassoci
protein
stain
phase
contrast
microscopi
although
mani
neurospher
sever
impact
infect
mani
other
display
gener
characterist
mockinfect
sphere
indic
chloroquin
treatment
rescu
neurit
extens
phenotyp
figur
furthermor
zikv
infect
decreas
neurospher
treat
chloroquin
evalu
stain
figur
chloroquin
known
nonspecif
antivir
agent
effect
zika
viru
replic
evalu
yet
first
report
inhibitori
effect
chloroquin
zikv
replic
given
ongo
epidem
may
becom
interest
scientif
knowledg
viru
clinic
perspect
although
zika
viru
first
identifi
uganda
januari
april
zikv
transmiss
report
countri
territori
zika
viru
diseas
gener
mild
recent
posit
correl
infect
congenit
malform
neurolog
damag
adult
intensifi
need
therapeut
approach
prophylact
treatment
women
intend
get
pregnant
epidem
area
travel
go
affect
countri
would
repres
relev
tool
reduc
zikv
transmiss
avoid
spread
diseas
travel
moreov
drug
block
placent
transfer
viru
could
decreas
chanc
vertic
transmiss
virem
pregnant
women
shown
hivinfect
pregnant
women
treat
antiretrovir
therapi
demonstr
chloroquin
decreas
number
zikvinfect
cell
protect
cell
zikv
infect
measur
cell
viabil
noncytotox
concentr
figur
figur
figur
concentr
chloroquin
protect
cell
zikv
infect
assess
cell
viabil
depend
cell
model
rang
tabl
valu
obtain
zikv
lower
obtain
denv
inhibit
hiv
inhibit
furthermor
observ
similar
zikv
inhibitori
effect
chloroquin
test
differ
zikv
lineag
infect
figur
figur
support
idea
chloroquin
could
help
manag
recent
infect
caus
asian
zikv
lineag
although
chloroquin
shown
antivir
activ
larg
spectrum
virus
vitro
clinic
studi
perform
evalu
chloroquin
effect
patient
viral
infect
two
clinic
trial
studi
chloroquin
conduct
assess
chloroquin
treatment
patient
infect
denv
one
trial
evalu
benefit
chloroquin
treatment
day
patient
infect
denv
show
reduct
durat
intens
denv
viremia
nonstructur
protein
antigenemia
clearanc
howev
trend
toward
reduct
number
dengu
hemorrhag
fever
case
notic
chloroquinetr
group
recent
clinic
trial
chloroquin
administr
denvinfect
patient
also
day
show
patient
chloroquinetr
group
report
feel
less
pain
show
improv
perform
daili
chore
treatment
moreov
symptom
return
medic
withdraw
howev
chloroquin
treatment
reduc
durat
intens
fever
durat
diseas
antivir
effect
chloroquin
may
insuffici
produc
decreas
viral
load
improv
diseas
progress
chloroquinehydroxychloroquin
use
monotherapi
howev
chloroquin
may
produc
signific
antiflavivir
effect
use
combin
therapi
recent
shown
clinic
trial
hydroxychloroquin
plu
ribavirin
interferon
alpha
individu
infect
hepat
c
viru
hcv
regard
potenti
antivir
therapeut
combin
zika
freshli
publish
screen
drug
alreadi
approv
clinic
indic
result
identif
candid
drug
note
one
mefloquin
compound
relat
chloroquin
term
safeti
pregnant
women
howev
mefloquin
includ
b
categori
ie
drug
anim
reproduct
studi
fail
demonstr
risk
fetu
adequ
wellcontrol
studi
pregnant
women
may
aforement
studi
corrobor
result
use
chloroquin
provid
new
antizikv
drug
could
test
combin
chloroquin
differ
mefloquin
administr
use
chloroquin
pregnanc
thoroughli
evalu
prophylact
dose
chloroquin
administ
malaria
mgweek
increment
birth
defect
observ
higher
concentr
chloroquin
mg
mgday
administ
pregnant
women
sever
diseas
lupu
rheumatoid
arthriti
studi
case
abort
fetal
toxic
observ
howev
fetal
toxic
death
could
discard
direct
consequ
diseas
addit
term
deliveri
result
healthi
newborn
chloroquin
success
test
anim
model
twice
daili
administr
chloroquin
mgkg
shown
increas
balbc
mice
surviv
rate
infect
ebola
viru
ebov
mice
model
coronaviru
infect
chloroquin
mgkg
protect
suckl
mice
infect
human
coronaviru
administ
pregnant
mice
day
prepartum
surviv
rate
observ
balbc
mice
infect
avian
influenza
viru
treat
chloroquin
mgkgday
result
suggest
chloroquin
potenti
inhibit
zikv
vivo
mous
studi
chloroquin
wide
distribut
bodi
tissu
well
analogu
hydroxychloroquin
concentr
hydroxychloroquin
brain
time
higher
plasma
concentr
chloroquin
plasma
reach
daili
intak
mg
prescrib
arthriti
patient
chloroquin
abl
cross
placent
barrier
suppos
reach
similar
concentr
matern
fetal
plasma
concentr
chloroquin
similar
valu
calcul
tabl
achiev
plasma
current
chloroquin
administr
protocol
might
reach
brain
differ
mechan
chloroquin
inhibit
viral
infect
describ
observ
strong
reduct
releas
zikv
particl
drug
ad
h
postinfect
figur
suggest
higher
impact
earli
stage
infect
possibl
fusion
envelop
protein
endosom
membran
chloroquin
inhibit
acidif
endosom
consequ
inhibit
low
phinduc
conform
chang
requir
fusion
envelop
protein
flavivirus
endosom
membran
chloroquin
also
effect
decreas
viru
releas
although
less
pronouncedli
statist
signific
ad
earli
stage
viru
infect
h
postinfect
suggest
later
stage
zikv
replic
cycl
might
also
affect
figur
zikv
detect
cerebrospin
fluid
zikvinfect
adult
patient
manifest
meningoenceph
indic
zikv
invad
central
nervou
system
yet
unknown
mechan
transcytosi
endotheli
cell
blood
brain
barrier
known
mechan
viral
access
central
nervou
system
demonstr
differ
methodolog
chloroquin
protect
hbmec
immort
cell
line
wide
use
vitro
model
barrier
zikv
infect
figur
recent
studi
show
neural
stem
cell
highli
permiss
zikv
infect
one
mechan
propos
caus
microcephali
would
deplet
stem
cell
pool
induc
zikv
data
show
chloroquin
inhibit
infect
human
neural
stem
cell
figur
use
mous
neurospher
model
studi
neural
stem
cell
differenti
neuron
anoth
process
might
disturb
microcephali
observ
chloroquin
inhibit
infect
neuron
progenitor
partial
protect
abil
cell
extend
neurit
figur
protect
effect
chloroquin
stem
cell
commit
progenitor
potenti
groundbreak
featur
compound
would
prescrib
women
childbear
age
travel
affect
countri
women
plan
pregnanc
endem
area
would
decreas
chanc
infect
thu
fetal
damag
especi
develop
brain
result
suggest
chloroquin
concentr
inhibit
zikv
replic
vitro
may
overlap
highest
drug
concentr
detect
human
therefor
suggest
therapeut
potenti
chloroquin
zika
subject
studi
